STOCK TITAN

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

TELA Bio (NASDAQ: TELA), a commercial-stage medical technology company specializing in soft-tissue reconstruction solutions, has announced its participation in Piper Sandler's 36th Annual Healthcare Conference. The company's management team will deliver a presentation on December 3rd, 2024, at 12:00 pm ET. Investors and interested parties can access both the live presentation and archived webcast through the company's investor relations website at ir.telabio.com.

TELA Bio (NASDAQ: TELA), una società di tecnologia medica in fase commerciale specializzata in soluzioni per la ricostruzione dei tessuti molli, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler. Il team di gestione dell'azienda presenterà il 3 dicembre 2024, alle 12:00 ET. Gli investitori e le parti interessate possono accedere sia alla presentazione dal vivo che alla registrazione web attraverso il sito web per le relazioni con gli investitori dell'azienda all'indirizzo ir.telabio.com.

TELA Bio (NASDAQ: TELA), una empresa de tecnología médica en etapa comercial especializada en soluciones para la reconstrucción de tejidos blandos, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. El equipo de gestión de la empresa realizará una presentación el 3 de diciembre de 2024, a las 12:00 pm ET. Los inversores y partes interesadas pueden acceder tanto a la presentación en vivo como a la retransmisión archivada a través del sitio web de relaciones con inversores de la empresa en ir.telabio.com.

TELA Bio (NASDAQ: TELA), 상업 단계의 의료 기술 회사로 연부 조직 재건 솔루션을 전문으로 하는 TELA Bio는 Piper Sandler의 제36회 연례 의료 컨퍼런스에 참가한다고 발표했습니다. 회사의 경영진은 2024년 12월 3일 오후 12시 ET에 발표를 진행할 예정입니다. 투자자와 관심 있는 관계자들은 회사의 투자자 관계 웹사이트 ir.telabio.com을 통해 라이브 프레젠테이션과 보관된 웹캐스트에 접근할 수 있습니다.

TELA Bio (NASDAQ: TELA), une entreprise de technologie médicale en phase commerciale spécialisée dans les solutions de reconstruction des tissus mous, a annoncé sa participation à la 36ème Conférence Annuelle sur la Santé de Piper Sandler. L'équipe de direction de l'entreprise fera une présentation le 3 décembre 2024 à 12h00 ET. Les investisseurs et les parties intéressées peuvent accéder à la fois à la présentation en direct et au webcast archivé via le site web de relations investisseurs de l'entreprise à l'adresse ir.telabio.com.

TELA Bio (NASDAQ: TELA), ein Unternehmen für Medizintechnik in der kommerziellen Phase, das sich auf Rekonstruktionslösungen für Weichgewebe spezialisiert hat, hat seine Teilnahme an der 36. Jahreskonferenz im Gesundheitswesen von Piper Sandler angekündigt. Das Management-Team des Unternehmens wird am 3. Dezember 2024 um 12:00 Uhr ET eine Präsentation halten. Investoren und Interessierte können sowohl auf die Live-Präsentation als auch auf die archivierte Webcast über die Investor-Relations-Website des Unternehmens unter ir.telabio.com zugreifen.

Positive
  • None.
Negative
  • None.

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 36th Annual Healthcare Conference.

TELA’s management is scheduled to present at Piper Sandler’s 36th Annual Healthcare Conference at 12:00 pm ET on December 3rd, 2024. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com


FAQ

When is TELA Bio presenting at Piper Sandler's Healthcare Conference 2024?

TELA Bio is scheduled to present at Piper Sandler's 36th Annual Healthcare Conference on December 3rd, 2024, at 12:00 pm ET.

How can investors watch TELA Bio's presentation at the Piper Sandler Conference?

Investors can watch both the live presentation and archived webcast through TELA Bio's investor relations website at ir.telabio.com.

What is TELA Bio's main business focus?

TELA Bio is a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions.

Which stock exchange is TELA Bio listed on?

TELA Bio is listed on the NASDAQ stock exchange under the ticker symbol TELA.

TELA Bio, Inc.

NASDAQ:TELA

TELA Rankings

TELA Latest News

TELA Stock Data

113.18M
33.31M
7.32%
51.7%
0.85%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MALVERN